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Abstract
Background: To ensure sustainable aquaculture, fish derived raw materials are replaced by vegetable ingredients. Fatty acid
composition and contaminant status of farmed Atlantic salmon (Salmo salar L.) are affected by the use of plant ingredients
and a spillover effect on consumers is thus expected. Here we aimed to compare the effects of intake of Atlantic salmon fed
fish oil (FO) with intake of Atlantic salmon fed a high proportion of vegetable oils (VOs) on development of insulin resistance
and obesity in mice.
Methodology/principal findings: Atlantic salmon were fed diets where FO was partly (80%) replaced with three different
VOs; rapeseed oil (RO), olive oil (OO) or soy bean oil (SO). Fillets from Atlantic salmon were subsequently used to prepare
Western diets (WD) for a mouse feeding trial. Partial replacement of FO with VOs reduced the levels of polychlorinated
biphenyls (PCB) and dichloro-diphenyl-tricloroethanes (DDT) with more than 50% in salmon fillets, in WDs containing the
fillets, and in white adipose tissue from mice consuming the WDs. Replacement with VOs, SO in particular, lowered the n23
polyunsaturated fatty acid (PUFA) content and increased n26 PUFA levels in the salmon fillets, in the prepared WDs, and in
red blood cells collected from mice consuming the WDs. Replacing FO with VO did not influence obesity development in
the mice, but replacement of FO with RO improved glucose tolerance. Compared with WD-FO fed mice, feeding mice WD-
SO containing lower PCB and DDT levels but high levels of linoleic acid (LA), exaggerated insulin resistance and increased
accumulation of fat in the liver.
Conclusion/Significance: Replacement of FO with VOs in aqua feed for farmed salmon had markedly different spillover
effects on metabolism in mice. Our results suggest that the content of LA in VOs may be a matter of concern that warrants
further investigation.
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Introduction
The ability of marine n23 polyunsaturated fatty acids (PUFAs)
to protect against the development of cardiovascular disease is well
documented [1–3]. Thus, increasing the dietary intake of n23
PUFAs is currently recommended by several health authorities.
During the recent years, there has been increasing focus on the
possible ability of n23 PUFAs to protect against other life-style
diseases such as obesity and type 2 diabetes. Although human
studies are inconclusive [4], rodent feeding trials demonstrate that
marine n23 PUFAs are able to protect against development of
obesity [5–10], and insulin resistance [9,11–15]. Fish and seafood,
in particular fatty fish such as Atlantic salmon (Salmo salar L.), are
rich in n23 PUFAs. Thus, both health authorities and consumers
have accepted farmed Atlantic salmon as part of a healthy diet.
Farmed Atlantic salmon have traditionally been fed diets with high
levels of fish meal and fish oil (FO), and a single meal of 200 g
Atlantic salmon, providing 4 g of n23 PUFAs, would be sufficient
to cover more than the weekly recommended intake of n23
PUFAs [16]. However, due to the pressure on wild fish stocks, and
hence limited access and variable prices of fish meal and FO for
the rapidly growing global aquaculture industry [17], efforts are
channeled towards development of aqua feed that rely less on fish
meal and FO [18,19].
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Vegetable oils (VOs) are presently recognized as suitable
alternatives in aqua feed [20], and consequently, the nutrient
composition in the Atlantic salmon fillets will change [16].
Although the Atlantic salmon have the ability to elongate and
desaturate fatty acids [21,22], Atlantic salmon fed vegetable feed
have lower content of marine n23 PUFAs [16,22] and a direct
relationship has been reported between marine n23 PUFA
content in aqua feed, Atlantic salmon fillets and plasma in patients
with coronary heart disease (CHD) consuming the fillets [23].
Documentation related to the health beneficial effects of fish has
almost exclusively been based on trials using FO, and therefore
focused on the content of marine n23 PUFAs in seafood. Thus, an
important question is whether the health beneficial effects are
preserved when the Atlantic salmon are fed VOs at the expense of
FO. A recent study by Alvheim et al. has demonstrated that an
increased content of linoleic acid (LA) from soybean oil (SO) in
salmon feed increased the endocannabinoid tone, both in the
Atlantic salmon and in the mice fed diets containing the salmon
fillets [24]. The increased endocannabinoid tone in the mice was
accompanied by increased weight gain.
Persistent organic pollutants (POPs) accumulate in lipid-rich
food, and thus, Atlantic salmon represent a source of POPs in
addition to marine n23 PUFAs. The levels of POPs in wild fish
are determined by factors including fat content, prey and
geographic location (Seafood data, www.nifes.no), whereas
contamination in farmed fish mainly depends on the composition
of the fish feed [25]. Thus, replacing marine ingredients in aqua
feed with vegetable sources will change the composition of
nutrients and the type and levels of POPs in the fish fillets
[25,26]. For instance, Atlantic salmon fed higher amounts of
vegetable ingredients have lower fillet levels of dioxins and
polychloridinated biphenyl (PCB) congeners compared to salmon
fed FO [25]. This may be of importance for the consumers as POP
exposure has been associated with development of type 2 diabetes
in humans [27–31]. We have recently demonstrated that intake of
purified salmon oil attenuated development of insulin resistance
and obesity in Wistar rats, whereas intake of crude salmon oil
containing POPs exaggerated obesity development [32]. More-
over, we have recently shown that chronic consumption of Atlantic
salmon with a high level of POPs caused insulin resistance and
obesity in mice [33]. When the levels of POPs in the salmon were
reduced, development of insulin resistance and obesity in the mice
decreased concomitantly [33].
Since both the nutrient and contaminant status of Atlantic
salmon are affected by the use of plant-based feed ingredients, a
spillover effect on consumer health might be expected. In the
present study we compared the development of insulin resistance
and obesity in mice fed a western type diet containing either
Atlantic salmon fed FO or Atlantic salmon where the FO in the
feed was replaced by a high proportion of VOs. Our results
indicate that the altered fatty acid composition, the increased
content of linoleic acid (LA) in particular, rather than the altered
content of POPs, in fillets from Atlantic salmon, influenced
development of insulin resistance and hepatic accumulation of
lipids in mice.
Materials and Methods
Ethical Statement
Animal handling and experiments were performed in accor-
dance with the guidelines of the Norwegian State Board of
Biological Experiments with Living Animals (Norwegian approval
identification nr, FOTS Id: 3196). No adverse events were
observed.
Production of Atlantic Salmon
The salmon feeding trial was carried out at Skretting ARC, Fish
Trials Station, Stavanger, Norway. A total of 600 Atlantic salmon
(Salmo salar L.), mean weight 815628 g, were randomly distributed
in 12 tanks. The salmon were divided into four experimental
groups and fed different experimental diets for 28 weeks as
described earlier [22]. The fat source in the control diet was 100%
FO, whereas 80% of the FO was replaced by rapeseed oil (RO),
olive oil (OO), or soy bean oil (SO), in the experimental diets.
These oils were chosen based on their different n26 PUFA
Table 1. Composition of the experimental mice diets (g/kg).
WD-FO WD-RO WD-OO WD-SO LF WD
Components added (g/kg)
Casein 97 97 97 97 197 197
Protein from
salmon
100 100 100 100 – –
Milk fat,
anhydrous
138 131 129 135 – 200
Fat from salmon 62 69 71 65 – –
Corn oil 10 10 10 10 70 10
Corn Starch 38 46 41 41 – 50
Maltodextrin 100 100 100 100 539 100
Sucrose 340 340 340 340 90 340
Analyzed
Fat (g/kg) 203 203 195 200 47 194
Crude protein
(N*6.25) (g/kg)
171.2 162.9 163.6 163.6 173.1 156.2
Energy kJ/g 21.2 21.1 21.0 21.1 17.1 20.7
All diets were supplemented with 40 mg/kg ethoxyquin, 2g/kg Choline
bitartrate, 4g/kg calcium carbonate, 10g/kg Vitamin mix V1001, 35g/kg Mineral
mix, 3g/kg L-Methionine and 50g/kg cellulose. Cholesterol levels in WDs were
balanced to a final concentration of 1.5 g/kg.
Analyzed values represent the mean of duplicate measurements.
doi:10.1371/journal.pone.0053094.t001
Table 2. Fatty acid composition of the experimental mice
diets.
WD-FO WD-RO WD-OO WD-SO LF WD
Sum SFA (mg/g) 93.2 78.8 84.2 85.2 7.1 103.5
Sum MUFA (mg/g) 58.2 67.1 73.4 55.4 7.6 50.8
LA, 18:2n26 (mg/g) 9.6 15.6 15.3 25.8 8.0 8.1
AA, 20:4n26 (mg/g) ,0.1 0.3 0.3 ,0.1 ,0.1 ,0.1
Sum n26 (mg/g) 10.5 17.3 17.0 28.5 8.1 8.3
ALA, 18:3n23 (mg/g) 1.8 3.9 2.7 2.7 1.0 1.0
EPA, 20:5n23 (mg/g) 4.1 1.3 1.2 1.2 ,0.1 0.1
DHA, 22:6n23 (mg/g)6.2 2.6 2.5 2.3 ,0.1 ,0.1
Sum n23 (mg/g) 18.4 10.9 9.2 9.2 1.1 2.5
n23/n26 ratio 1.75 0.63 0.54 0.32 0.13 0.29
Data represent mean of duplicate measurements. Sum n23 and sum n26
include additional fatty acids not indicated in the table.
Abbreviations: ALA, a-linolenic acid; AA, arachidonic acid; DHA,
docosahexaenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid, MUFA,
monounsaturated fatty acids; SFA, saturated fatty acids.
doi:10.1371/journal.pone.0053094.t002
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content [22]. In all diets 70% of fish meal was replaced with plant
proteins. The complete dietary compositions and analyses of the
diets and fillets have been reported earlier [22]. Upon sampling,
salmon fillets were freeze dried, homogenized and analyzed for fat
and protein content.
Mouse Diets
All diets formulations were based on the standard Western diet
(WD), D12079B Research Diets, Inc. NJ, USA prepared by Ssniff
Spezialdia¨ten (Soest, Germany). We replaced 50% of the protein
source in the standard Western diet with proteins from salmon fed
FO, RO, OO or SO. Since the fat content differed in salmon fed
the different diets, milk fat was used to achieve isocaloric diets. The
major fatty acid source in the milk fat used was 16:0, 18:1, 14:0
and 18:0, representing, 29, 26, 10 and 11%, respectively.
Composition of the mice diets are shown in Table 1. As
references, two groups of mice were fed either a casein based
standard WD (Ssniff S8672), or a regular low fat diet (LF),
D12450B (Ssniff EF R/M Control, Germany). Complete fatty acid
composition of the WD and LF diet is available at http://www.
ssniff.com/documents/10_catalogue_ef_engl_1.pdf.
Animals
48 male C57BL/6J BomTac mice were obtained from
Taconic (Ejby, Denmark) at 8 weeks of age. The mice were
maintained in a controlled environment with an artificial 12-h-
light/dark cycle at thermoneutrality (30uC). Before the start of
the feeding experiment animals were allowed to acclimatize to a
regular LF diet for 5 d. After acclimatization, the mice were
housed individually and randomly assigned to the experimental
diets.
The animals were fed the experimental diets described in
Table 1 for 10 weeks ad libitum. Throughout the experiment, all
mice were weighed once a week and feed intake was assessed every
Monday, Wednesday and Friday.
Insulin and Glucose Tolerance Tests (ITT and GTT)
ITT and GTT were performed on conscious mice after 7
and 8 weeks of feeding, respectively. ITT was performed in fed
state by intraperitoneal (i.p.) injection of insulin (Actrapid, Novo
Nordisk, Bagsværd, Denmark, 0,75 U/kg body weight). GTT
was performed in 6 h fasted mice by i.p injection of glucose
(2.0 mg/g body weight). Blood was collected from the lateral
tail vein and glucose levels were measured at different time-
points using a glucometer (Ascensia Contour, Bayer Healthcare,
Oslo, Norway). For the GTT, incremental area under the curve
(AUC) was calculated as blood glucose concentrations above
baseline levels.
Plasma and Tissue Sampling
At the end of the feeding period, overnight fasted mice were
sacrificed by cardiac puncture under Isoflurane anesthesia
(Isoba-vet, Schering-Plough, Denmark). Liver, muscles, and
adipose tissue depots were quickly dissected out, weighed,
snap-frozen in liquid nitrogen and stored at 280uC for further
analyses. Blood was collected in tubes containing 10 ml heparin
(10 mg/ml, Sigma-Aldrich, United Kingdom), and plasma was
prepared by centrifugation. Red blood cells (RBCs) and plasma
were stored in aliquots at 280uC for further use.
Plasma Analyses
A commercial ELISA kit was used in accordance with the
manufacturer’s instruction for determination of plasma insulin
(Mouse Insulin ultrasensitive ELISA, DRG, Marburg, Germany).
Plasma glucose was determined using an automated analyzer
(Maxmat PLll, Multi-purpose diagnostic analyzer system, Mon-
tpellier, France).
Lipid Analyses
Total fat content in the diets was measured gravimetrically after
acidic hydrolysis and petroleum ether extraction. Tissue lipids
were extracted from liver and muscle samples with chloroform:
methanol, 2:1 (v/v). Lipid classes were analyzed using an
automated High Performance Thin Layer Chromatography
(HPTLC) system (Camaq, Switzerland) and separated on HPTLC
plates coated with silica gel 60 F [34]. Fatty acid composition of
total lipids in red blood cells was analyzed on a capillary gas
chromatograph with flame ionization detector (Perkin Elmer,
USA) [35].
Energy in Feces and Diets
Energy content was determined in a bomb calorimeter
following the manufacturer’s instruction (Parr Instruments, Mo-
line, IL, USA).
Contaminant Analyses
The levels of 7 polychlorinated biphenyls (7 PCBs) and dichloro-
diphenyl-tricloroethanes (DDTs) in salmon fillets, mouse feed, liver
and adipose tissue from mice were analyzed as described earlier
[33]. The 7 PCBs comprise PCB 28, 52, 101, 118, 138, 153 and
180). DDTs comprise op9-DDT, pp9-DDT, op9-DDD, pp9-DDD,
op9-DDE and pp9-DDE.
Statistics
All data are presented as mean 6 SEM. Statistical significance
was analyzed by using one-way ANOVA, with Dunnett’s Multiple
Comparisons test as post hoc test. All groups were compared
against the group receiving WD containing salmon fed FO. To
compare plasma glucose concentrations during the GTT and ITT
over time and between dietary treatments, a 2-way repeated-
measures ANOVA was applied. Statistical analysis was performed
using Graph Pad Prism version 5.04 (GraphPad Software Inc, La
Jolla, CA, USA). *, ** and ***represents significant different from
WD containing salmon fed FO at P,0.05, P,0.01 and P,0.001
levels, respectively.
Results
Replacing Fish Oil with Vegetable Oils in Fish Feed
Reduces the n23/n26 Ratio in Atlantic Salmon Fillets
and in the Red Blood Cells from Mice Consuming the
Salmon Fillets
It is well known that replacing FO with VO in fish feed changes
the composition of both nutrients and POPs in Atlantic salmon
fillets [22,25], but the spillover effects of such changes for the
consumers are not thoroughly examined. To investigate this,
Atlantic salmon were fed diets in which 70% of marine proteins
were exchanged with vegetable proteins and 80% of the FO were
exchanged with VO. The VOs used were rape seed oil (RO), olive
oil (OO) and soybean oil (SO), chosen based on their different
content of n26 PUFAs [22]. Compositions of the salmon diets are
listed in Liland et al. 2012 [22]. To investigate the potential
spillover implications of such changes in the aqua feed for
consumers, we prepared standard WDs containing these salmon
filets, replacing 50% of the protein source (casein) with protein
from salmon (Table 1). The fat content was slightly different in
Farmed Atlantic Salmon and Insulin Resistance
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Figure 1. Composition of salmon aqua feed changes n23/n26 PUFA ratio in mice consuming the salmon fillets. Fish oil (FO) in aqua
feed was partly replaced with rapeseed oil (RO), olive oil (OO) or soy bean oil (SO) and fed Atlantic salmon. The salmon fillets were used in Western
diets (WDs) fed male C57BL/6J mice (n = 8/diet) for 10 weeks. Fatty acid composition was measured and the n23/n26 PUFA ratio calculated in (A)
Atlantic salmon fillets (B) the WDs containing the fillets and (C) red blood cells (RBC) collected from mice consuming the WDs and reference diets.
Data represent mean of duplicate measurements in A and B and mean+SEM (n= 5) in C. Asterisk(s) indicates significant different from FO-WD.
doi:10.1371/journal.pone.0053094.g001
Farmed Atlantic Salmon and Insulin Resistance
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salmons fed the different feeds, and milk fat, used as fat source in
the standard WD diet, was used to achieve isocaloric diets
(Table 1). To verify the expected differences in fatty acid
composition in the mouse diets, hereafter referred to as WD-FO,
WD-RO, WD-OO, and WD-SO, analyses of the diets were
performed (Table 2). The diets containing salmon fed either of the
VOs, hereafter collectively referred to as WD-VOs, had signifi-
cantly lower, but comparable levels of the marine n23 PUFAs,
EPA and DHA, than WD-FO (Table 2). Compared with WD-FO,
the levels of n26 PUFAs were higher in WD-VOs (Table 2). Of
note, the levels of LA were comparable in WD-RO and WD-OO,
but particularly high in WD-SO (Table 2). Furthermore, the levels
of the vegetable n23 PUFA, a-linolenic acid (ALA) was higher in
the WD-RO than the other WD-VOs (Table 2). Thus, the n23/
n26 ratio varied between the WD-VOs. The n23/n26 ratio was
lower in WD-OO than in WD-RO, and the lowest n23/n26
ratio was measured in the WD-SO (Table 2).
To investigate possible spillover effects for consumers, C57BL/
6J mice were fed these diets for 10 weeks and fatty acid
composition was measured in the red blood cells (RBC). As
references, two groups of mice were fed either a standard casein
based WD or a regular low fat (LF) diet. As predicted, the
combined levels of n26 PUFAs were higher and the levels of n23
PUFAs lower in RBCs in mice fed WD-VOs compared with WD-
FO (Table 3). Thus, the n23/n26 ratio in RBCs in the mice
reflected the ratio in the salmon fillets and mouse diets (Fig. 1).
Compared with the WD-FO diet all the WD-VOs significantly
reduced the omega-3 index - with over 30% reduction in mice fed
the WD-SO diet compared to mice fed the WD-FO diet (Table 3).
The omega-3 indices were reduced 18 and 21% in WD-RO and
WD-OO fed mice, respectively (Table 3). However, all mice fed
diets containing salmon had an omega-3 index higher than 8%
[2], indicating that intake of the WD-VO diets still might exert a
cardio-protective effect. For comparison, the reference diets
resulted in an omega-3 index below the recommended limit of 8%.
Replacing Fish Oil with Vegetable Oils in Fish Feed
Reduces the Levels of PCBs and DDTs in Atlantic Salmon
Fillets and Accumulation of these in Adipose Tissue from
Mice Consuming the Salmon Fillets
When FO was replaced with VO in salmon feed, the levels of
PCBs and DDTs were reduced by more than 50% in the salmon
fillets (Fig. 2A). PCBs and DDTs are lipid soluble contaminants
that accumulate in adipose tissue in rats and mice [32,33]. Thus,
the contaminant levels in adipose tissue, but not in liver of the mice
mirrored the levels in the salmon fillets and the mouse diets (Fig. 2).
Together, changes in the salmon feed were translated into altered
fatty acid composition in RBCs and levels of POPs in adipose
tissue in mice consuming the salmon fillets.
The Nutrient- and Contaminant Changes in Salmon
Fillets do not Influence Obesity Development in Mice
We have previously demonstrated that chronic consumption of
commercially available Atlantic salmon with a high level of POPs
caused obesity in obesity prone C57BL/6J mice [33]. When the
levels of POPs in the salmon were reduced, obesity development in
the mice were slightly, but significantly, decreased. Here we
demonstrate that although the accumulation of both PCBs and
DDTs in adipose tissue was significantly lower in mice fed the
various WD-VOs than in mice fed WD-FO, (Fig. 2C) body weight
gain (Table 4) and adipose tissue masses (Table 5) were
comparable. As expected, mice fed the LF diet, consumed
significantly less energy and gained less weight than WD-FO fed
mice. However, energy intake and apparent fat digestibility in the
WD-VOs fed mice were comparable to those of mice fed the WD-
FO (Table 4). Thus, neither reduced levels of PCBs and DDTs nor
lower n23/n26 ratio in the WD-VOs had any effect on the body
weight or obesity development (Table 4 and 5).
Table 3. Fatty acid composition in RBCs from mice after consuming the experimental diets for 10 weeks.
WD-FO WD-RO WD-OO WD-SO LF WD
Sum FA (mg/g) 3.160.2 3.160.2 3.260.1 3.260.2 3.160.1 3.160.1
Sum SFA (mg/g) 1.2660.06 1.1460.01* 1.1860.02 1.1960.01 1.1860.01 1.1360.02*
Sum MUFA (mg/g) 0.5860.03 0.5960.01 0.6660.01* 0.5160.02 0.6160.02 0.7060.02***
LA, 18:2n26 (mg/g) 0.2360.02 0.3260.01*** 0.3260.02** 0.3760.01*** 0.2960.02* 0.2660.01
AA, 20:4n26 (mg/g) 0.2260.01 0.2560.01 0.2760.01** 0.3260.01*** 0.5660.02*** 0.5160.01***
Sum n26 (mg/g) 0.4960.03 0.6560.02*** 0.6960.01*** 0.8260.02*** 0.9760.01*** 0.9160.02***
EPA, 20:5n23 (mg/g) 0.2160.01 0.1560.01*** 0.1360.01*** 0.0960.01*** 0.0160.00*** 0.0260.00***
DHA, 22:6n23 (mg/g) 0.4060.02 0.3460.00** 0.3560.00* 0.3460.01** 0.2360.01*** 0.2260.01***
Sum n23 (mg/g) 0.7360.04 0.5960.01*** 0.5860.01*** 0.5160.01*** 0.2860.01*** 0.3160.01***
Calculated n26 HUFA (%) 26.660.2 36.160.5*** 39.4.060.6*** 47.560.5*** 7161*** 68.060.6***
Calculated n23 index (%) 19.460.1 15.960.2*** 15.260.2*** 13.360.3*** 7.760.1*** 7.860.2***
The n23 index: EPA+ DHA content of erythrocytes expressed as a percent of total fatty acids in RBCs. Sum n23 and sum n26 include additional fatty acids not
indicated in the table.
Data are presented as mean 6 SEM (n = 5). Asterisk(s) indicates significant different from WD-FO.
*p,0.05,
**p,0.01,
***p,0.005.
Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid, EPA, eicosapentaenoic acid, FA, fatty acids; HUFA, highly unsaturated fatty acids (HUFA, $20 carbons
and $3 carbon-carbon double bonds), LA, linoleic acid; MUFA, monounsaturated fatty acids; RBCs, red blood cells; SFA, saturated fatty acids.
doi:10.1371/journal.pone.0053094.t003
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Figure 2. Composition of salmon aqua feed changes accumulation of POPs in mice consuming the salmon fillets. Fish oil (FO) in aqua
feed was partly replaced with rapeseed oil (RO), olive oil (OO) or soy bean oil (SO) and fed Atlantic salmon. The salmon fillets were used in Western
diets (WDs) fed male C57BL/6J mice (n = 8/diet) for 10 weeks. Concentrations of 7PCBs and DDTs were measured in (A) Atlantic salmon fillets (B) the
WDs containing the fillets and (C) epididymal white adipose tissue (eWAT) and (D) liver collected from mice consuming the WDs and a low fat
reference diet. Data represent mean of duplicate measurements in A and B. Tissues from two animals were pooled to achieve sufficient material for
POP analyzes, and data in C and D thus represent mean+SEM (n= 4). Asterisk(s) indicates significant different from WD-FO.
doi:10.1371/journal.pone.0053094.g002
Farmed Atlantic Salmon and Insulin Resistance
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The Fatty Acid Composition in Salmon Fillets Influences
Development of Insulin Resistance and Hepatic Lipid
Accumulation in Mice
Given the earlier findings that POPs appear to exacerbate
insulin resistance [32,33], whereas n23 PUFAs have been
demonstrated to attenuate development of diet-induced insulin
resistance [9,11–15], we measured fasting levels of glucose and
insulin, and performed glucose and insulin tolerance tests.
Overnight fasting plasma glucose levels were comparable in all
groups (Fig. 3A). Compared with intake of WD-FO, intake of WD-
VOs did not affect plasma insulin levels (Fig. 3B). The glucose
tolerance in mice fed the WD-FO was comparable to the glucose
tolerance in mice fed the standard WD, but lower than in mice fed
the LF diet (Fig. 3C and E). WD-RO had a significantly decreased
incremental area under the curve (AUC) compared with WD-FO
(Fig. 3E) indicating an improved glucose tolerance. During the
insulin tolerance test, AUC in WD-RO fed mice was not
significantly lower than in mice fed WD-SO, but significantly
lower (p,0.05) than in WD-FO fed mice (Fig. 3D). Mice receiving
WD-SO had significantly higher blood glucose levels at 15 and
45 min after insulin injection than mice fed the WD-FO (Fig. 3D).
LF fed mice had lower plasma glucose 30 and 45 min after
injection of glucose (Fig. 3D). The difference was confirmed by a
repeated-measures ANOVA test during the ITT revealing that the
glucose response over time was significantly higher after in WD-
SO fed mice as compared to WD-FO fed mice (p,0.05), whereas
the glucose response over time in LF fed mice was significantly
lower (p,0.01). Furthermore, mice receiving WD-SO had
significantly larger AUC during ITT than mice fed the WD-FO
(Fig. 3F). These results suggest that insulin sensitivity in mice fed
WD-SO was decreased.
The reduced insulin sensitivity in WD-SO fed mice was not
associated with increased adipose tissue mass. However, as not
only increased adipose tissue mass, but also ectopic deposition of
lipids have been suggested to contribute to the development of
insulin resistance [11,36–38] we quantified lipids in liver and
the tibialis anterior muscle. We did not observe any significant
changes in muscle lipid content (not shown). Hepatic levels of
PL and free fatty acids were similar in all groups but mice fed
the WD-SO had significantly higher levels of total lipids, free
cholesterol, steryl ester (SE) and triacylglycerol (TAG) in the
liver than mice fed the WD-FO (Fig. 4). A similar tendency was
seen in mice fed the WD-OO, but due to large individual
differences this did not reach statistical significance. Given the
ability of n23 PUFAs to protect against diet-induced accumu-
lation of fat in liver [39,40], and the indication of increased
accumulation of lipids with increasing amount of n26 in the
diet, our data suggest that fatty acid composition in the salmon
fillets appears to play a more important role than the levels of 7
PCBs and DDTs.
Discussion
The acceptance of Atlantic salmon as part of a healthy diet has
to a large extent been based on its high content of marine n23
PUFAs. However, the traditional use of fish-derived raw materials
such as fish meal and FO in aquaculture is not sustainable due to
the pressure on wild fish stocks. Thus, VOs are presently
recognized as suitable alternatives in aqua feed [20]. We recently
Table 4. Body weight, energy intake, energy efficiency and apparent fat digestibility in mice fed the different diets for 10 weeks.
WD-FO WD-RO WD-OO WD-SO LF WD
Initial BW (g) 25.460.5 25.360.4 25.460.5 25.560.4 25.460.6 25.460.5
BW gain (g) 18.660.6 16.760.9 17.061.0 18.561.1 8.260.7*** 15.360.7*
Total energy intake (kJ) 41256140 40166127 41136231 40326195 34236133* 38406104
Energy efficiency (g/MJ) 4.560.2 4.260.3 4.260.4 4.660.2 2.460.2*** 4.060.2
Fat digestibility (%) 97.760.3 98.160.3 98.560.1 98.660.1 96.760.1 96.260.6**
Data are presented as means 6 SEM (n = 8). Asterisk(s) indicates significant different from WD-FO.
*p,0.05,
**p,0.01,
***p,0.005.
Abbreviations: BW, body weight.
doi:10.1371/journal.pone.0053094.t004
Table 5. Organ weights (g) in the mice fed the experimental diets for 10 weeks.
WD-FO WD-RO WD-OO WD-SO LF WD
Liver 1.3560.06 1.3360.03 1.5460.10 1.5960.14 1.1160.04 1.4760.05
eWAT 1.9860.05 1.9760.08 1.8760.16 1.9660.08 0.7060.08* 1.7960.08
iWAT 0.7060.02 0.6860.05 0.6560.09 0.7160.05 0.2560.03* 0.6360.05
iBAT 0.10260.006 0.08560.006 0.08960.008 0.10060.006 0.08060.007 0.08460.005
Muscle (Tibialis) 0.09160.004 0.08160.004 0.09760.006 0.09260.007 0.08960.005 0.08260.003
Data are presented as means 6 SEM (n = 8). Asterisk(s) indicates significant different from WD-FO.
*p,0.05,
**p,0.01,
***p,0.005.
Abbreviations; eWAT, epididymal white adipose tissue; iBAT, interscapular brown adipose tissue; iWAT, inguinal white adipose tissue.
doi:10.1371/journal.pone.0053094.t005
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demonstrated that a net production of marine proteins, but not
marine n23 PUFAs, is achievable when 70% of the marine
proteins and 80% of the marine oils are replaced by vegetable
alternatives [22]. Here we demonstrate that replacing FO with
RO, OO or SO, decreased the n23/n26 ratio in salmon fillets by
79, 76 and 92%, respectively, with a concomitant reduction in
Figure 3. Fatty acid composition in salmon fillets influences development of insulin resistance in mice. Male C57BL/6J mice (n = 8/diet)
were fed WD-FO, WD-RO, WD-OO and WD-SO for 10 weeks. As references, two groups of mice received regular WD or LF diet. Plasma glucose (A) and
insulin (B) were measured after overnight fasting. An intraperitoneal glucose tolerance test (GTT) was performed after 7 weeks of feeding (C) and an
intraperitoneal insulin tolerance test (ITT) was performed after 8 weeks of feeding (D). Area under the curve (AUC) was calculated from the glucose
tolerance (baseline was set to fasted blood glucose levels) (E) and insulin tolerance test (F). Data are presented as means+SEM (n = 8). *represents
significant different from WD-FO (P,0.05). **represents significant different from WD-FO (P,0.01). ***represents significant different from WD-FO
(P,0.005).
doi:10.1371/journal.pone.0053094.g003
Figure 4. Fatty acid composition in salmon fillets influences development of hepatic lipid accumulation in mice. Male C57BL/6J mice
(n = 8/diet) were fed WD-FO, WD-RO, WD-OO and WD-SO for 10 weeks. As references, two groups of mice received standard WD or LF diet. Lipids
were extracted from liver and (A) total lipids; (B) triacylglycerol (TAG); (C) free cholesterol, and (D) steryl ester (SE) were quantified. Data are presented
as means+SEM (n= 8). Asterisk(s) indicates significant different from WD-FO.
doi:10.1371/journal.pone.0053094.g004
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marine n23 PUFAs in RBCs collected from mice fed WDs
containing the salmon fillets. The omega-3 PUFA content in RBC
membranes reflects the levels in cardiac membranes, and an
omega-3 index below 4% is considered a risk factor for
cardiovascular disease [2]. The omega-3 index was lower in mice
fed the WD-VOs, WD-SO in particular, than in mice fed the WD-
FO, however, the omega-3 index remained above 8% in all mice
fed WDs containing salmon. Thus, the cardio-protective effects of
salmon ingestion appeared to be maintained in diets based on VO
fed salmon.
The ability of marine n23 PUFAs to protect against
development of obesity in rodents is well documented [5–10],
whereas n26 PUFAs, LA in particular, have been associated with
increased weight gain [10,41–44]. We recently demonstrated that
elevation of dietary LA from 1 to 8en% increased endocannabi-
noid tone and obesity development in mice, an effect that was
prevented by adding 1% EPA and DHA to the 8e% LA diets [10].
Furthermore, excessive dietary LA from SO in salmon feed
increased the endocannabinoid tone, both in Atlantic salmon and
in mice fed high fat diets containing the salmon fillets. The
increased endocannabinoid tone in the mice was accompanied by
increased weight gain [24]. Here, the WD-SO contained more
n26 PUFAs, mainly LA, than the WD-FO and the other WD-
VOs. Thus, the calculated n26 HUFA content in WD-SO fed
mice was significantly higher than in WD-FO and the other WD-
VO fed mice. However, obesity development and weight gain
were not influenced by replacing FO with VO in the present study.
Compared to WD-FO fed mice, glucose tolerance was comparable
in mice fed WD-OO and WD-SO, and actually improved in WD-
RO fed mice. Despite similar body weight, adipose tissue mass and
glucose tolerance, WD-SO fed mice became more insulin resistant
and accumulated more lipids in the liver than WD-FO fed mice.
Thus, in this study insulin resistance was accompanied by ectopic
fat accumulation rather than obesity. Although a causal relation-
ship is not fully established, hepatic insulin resistance is frequently
accompanied by excessive deposition of fat in the liver [37]. The
sequence of events leading to insulin resistance is not elucidated,
but it was recently demonstrated that development of diet-induced
hepatic insulin resistance precedes development of peripheral
insulin resistance [45]. The finding that WD-SO fed mice had
higher accumulation of hepatic TAG and were more insulin
resistant than WD-FO fed mice might thus be related to the fatty
acid composition of the diets. A number of studies have
demonstrated the ability of marine n23 PUFAs to prevent diet-
induced accumulation of hepatic TAG [2,46,47]. Of note, the
levels of the marine omega-3 fatty acids, EPA and DHA, were
comparable in all WD-VOs. However, the level of LA was higher
in WD-SO than in WD-OO and WD-RO. This might be of great
importance for the omega-3 index, as the conversion of LA to
arachidonic acid (AA), allows competition between AA and the
n23 PUFAs, EPA and DHA, for incorporation into membrane
phospholipids (PL) [10]. In the study by Alvheim et al, 100%
replacement of FO with SO in salmon feed led to increased LA
and decreased EPA and DHA levels in salmon liver and fillet [24].
The mice fed SO salmon had higher AA and lower EPA and
DHA levels in the PLs. Glucose tolerance and insulin resistance
were not measured in the study by Alvheim et al., but the lower
levels of EPA and DHA were accompanied with a 2.5-fold
increased accumulation of hepatic TAG in mice fed SO salmon.
Although a cause relationship is not demonstrated, it is possible
that the high levels of n26 PUFAs, LA in particular, in the WD-
SO attenuated the ability of marine n23 PUFA to reduce hepatic
TAG, and thereby contributed to the augmented insulin resistance
in WD-SO fed mice.
In the study by Alvheim et al., the Atlantic salmon were fed
refined and purified FO and SO. However, the oils commonly
used in the aquaculture industry contain POPs, and the use of
vegetable oils in aqua feed will introduce different POPs in
addition to changing the nutrient composition of salmon fillet.
This is an important aspect, as the POPs present in
commercially available farmed salmon are transferred to mice
consuming the salmon, and these POPs may contribute to
development of obesity and insulin resistance [32,33]. Chronic
long term consumption of commercially available Atlantic
salmon with current levels of POPs caused obesity and insulin
resistance in mice [33], and the accumulation of POPs in
adipose tissue was similar to levels in mice fed the WD-FO.
When the levels of POPs in the salmon were reduced, obesity
development and insulin resistance were slightly, but signifi-
cantly decreased [33]. In this study, however, neither obesity
nor insulin resistance correlated with accumulation of POPs in
adipose tissue. Since obesity in general is often associated with
insulin resistance, we cannot exclude the possibility that insulin
resistance in the earlier studies [32,33], at least in part, simply
reflected the degree of obesity. Laboratory rodents are normally
fed a diet where casein is used as the protein source. In a
previous salmon study, we replaced 100% of the casein with
salmon proteins [33]. Mice receiving salmon as the sole protein
source gained significantly more adipose tissue mass than mice
receiving casein. The increased adiposity was accompanied with
increased digestibility of fat. Thus, in order to limit the
difference in fat digestibility, we exchanged only 50% of the
casein with proteins from salmon in the present study. The
difference in fat digestibility between WD and WD-FO was still
significant with higher digestibility in the WD-FO. All the WD-
VOs had the same fat digestibility as WD-FO, suggesting that
the uptake of fat from the different WDs was comparable.
In the present experiment insulin resistance was more
pronounced in mice fed the WD-SO than in mice fed WD-
FO although the degree of adiposity was similar in all WD
groups. Of note, the levels of PCBs and DDTs reported to
accumulate in adipose tissue [33] were comparable to the levels
found after 10 weeks feeding with WD-FO in the present study,
whereas mice fed the WD-SO diet had lower accumulation of
PCBs and DDTs than reported for mice fed Atlantic salmon
with reduced POP levels [33]. Obviously, the levels of POPs in
adipose tissue are not the sole determining factor of insulin
resistance. We cannot exclude the possibility that POPs
contributed to the development of insulin resistance, but our
results suggest that other factors, such as fatty acid composition
in the diets, are of importance.
In view of the limited access to marine fish meal and fish oil for
the rapidly growing aquaculture industry, a global contributor to
food security, the use of alternative feed ingredients is inevitable.
Exchanging FO with VO in aquatic feed reduced the accumu-
lation of POPs in adipose tissue by more than 50% in mice
consuming the salmon. Importantly, in relation to replacement of
fish oil with vegetable oil in future feed for salmon farming, our
data clearly demonstrate that VOs have markedly different
spillover effects on metabolism in mice, and that the content of
LA may be a matter of concern. This raises the important question
as to whether similar effects will be observed in humans consuming
Atlantic salmon fed VOs, SO in particular, and in this context our
study suggests that RO and/or OO represent a better choice than
SO to replace FO.
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